 |
인쇄하기
취소
|
SK Chemicals launches Korea’s 13th new drug
SK Chemicals announced on November 1 its release of M-vix (mirodenafil), a homegrown impotence treatment. Its initial target is to record 10 billion won in sales next year.
Demonstrating the strength of the country's R&D capabilities, the Korean Food and Drug Administration approved M-Vix for the treatment of erectile dysfunction (ED). The drug is the 13th to be discovered in Korea in 8 year...
Demonstrating the strength of the country's R&D capabilities, the Korean Food and Drug Administration approved M-Vix for the treatment of erectile dysfunction (ED). The drug is the 13th to be discovered in Korea in 8 year...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.